Cargando…
Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
BACKGROUND: Current treatments for alcohol use disorders have limited efficacy and there is a high degree of variability in treatment response. In a randomised, placebo-controlled clinical trial, there was a large effect size for topiramate in people homozygous for the GRIK1 rs2832407*C allele. The...
Autores principales: | Morley, Kirsten C., Kranzler, Henry R., Luquin, Natasha, Baillie, Andrew, Shanahan, Marian, Trent, Ronald, Teesson, Maree, Haber, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097336/ https://www.ncbi.nlm.nih.gov/pubmed/30115121 http://dx.doi.org/10.1186/s13063-018-2824-z |
Ejemplares similares
-
Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial
por: Morley, Kirsten C, et al.
Publicado: (2013) -
Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats
por: Scudeler, Monica Alhadas, et al.
Publicado: (2022) -
Relationship between clinician-level attributes and implementation outcomes from the Pathways to Comorbidity Care training program
por: Louie, Eva, et al.
Publicado: (2022) -
An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol
por: Baillie, Andrew J, et al.
Publicado: (2013) -
Barriers and Facilitators to the Implementation of the Pathways to Comorbidity Care (PCC) Training Package for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings
por: Louie, Eva, et al.
Publicado: (2021)